- Home
- THR vs MDXG Comparison
THR vs MDXG Comparison
Compare THR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THR
- MDXG
- Stock Information
- Founded
- THR 1954
- MDXG 2006
- Country
- THR United States
- MDXG United States
- Employees
- THR N/A
- MDXG N/A
- Industry
- THR Industrial Machinery/Components
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- THR Energy
- MDXG Health Care
- Exchange
- THR Nasdaq
- MDXG Nasdaq
- Market Cap
- THR 887.4M
- MDXG 1.0B
- IPO Year
- THR 2011
- MDXG N/A
- Fundamental
- Price
- THR $25.94
- MDXG $6.43
- Analyst Decision
- THR Strong Buy
- MDXG Strong Buy
- Analyst Count
- THR 1
- MDXG 2
- Target Price
- THR $38.00
- MDXG $12.50
- AVG Volume (30 Days)
- THR 188.0K
- MDXG 852.6K
- Earning Date
- THR 05-22-2025
- MDXG 04-30-2025
- Dividend Yield
- THR N/A
- MDXG N/A
- EPS Growth
- THR 3.97
- MDXG N/A
- EPS
- THR 1.57
- MDXG 0.27
- Revenue
- THR $498,207,000.00
- MDXG $352,375,000.00
- Revenue This Year
- THR $8.84
- MDXG $9.44
- Revenue Next Year
- THR $6.23
- MDXG $11.54
- P/E Ratio
- THR $16.52
- MDXG $23.82
- Revenue Growth
- THR 0.72
- MDXG 5.34
- 52 Week Low
- THR $23.05
- MDXG $5.47
- 52 Week High
- THR $35.42
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- THR 39.49
- MDXG 38.95
- Support Level
- THR $25.58
- MDXG $6.46
- Resistance Level
- THR $30.17
- MDXG $6.90
- Average True Range (ATR)
- THR 0.92
- MDXG 0.23
- MACD
- THR -0.47
- MDXG -0.05
- Stochastic Oscillator
- THR 6.99
- MDXG 1.02
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.